Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Completed · Phase 2

Conditions studied: Non-Squamous Non-Small Cell Lung Cancer

In brief

This is a randomized, open-label, multicenter, phase 2 study comparing Paclitaxel/Carboplatin with or without bavituximab in patients that have previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC).

Key facts

Study ID
NCT01160601
Run by
Peregrine Pharmaceuticals
People needed
86
Starts
2010-06-01
Expected to finish
2013-09-01
Last updated by the study team
2017-04-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.